Caricamento...
COVID-19 Susceptibility in Bronchial Asthma
BACKGROUND: Bronchial asthma has not been adequately assessed in coronavirus disease 2019 (COVID-19). Respiratory allergy is associated with significant reductions in the expression of angiotensin-converting enzyme 2 receptor, which is the entry receptor for COVID-19. OBJECTIVE: To observe COVID-19...
Salvato in:
| Pubblicato in: | J Allergy Clin Immunol Pract |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7683297/ https://ncbi.nlm.nih.gov/pubmed/33242628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.11.020 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|